SCHEMBL5322254

SCHEMBL5322254

Cc1ccccc1CCC(N)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC1A5 Q15758 1/20 0.53
TAAR1 Q96RJ0 1/20 0.48
KIF11 P52732 10/20 0.48
ALPI P09923 1/20 0.46
PKM P14618 1/20 0.46
PTGS1 P23219 1/20 0.46
XIAP P98170 1/20 0.46
SLC7A5 Q01650 1/20 0.46
NOS3 P29474 1/20 0.45
NOS1 P29475 1/20 0.45
NOS2 P35228 1/20 0.45
GRIK1 P39086 1/20 0.43
GRIA1 P42261 1/20 0.43
GRIA2 P42262 1/20 0.43
GRIA3 P42263 1/20 0.43
GRIA4 P48058 1/20 0.43
GRIK2 Q13002 1/20 0.43
GRIK3 Q13003 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8819746 1.00 SLC1A5 (0.53) SLC1A5TAAR1KIF11ALPIPKM
SCHEMBL30963028 1.00 SLC1A5 (0.53) SLC1A5TAAR1KIF11ALPIPKM
SCHEMBL8819750 1.00 SLC1A5 (0.53) SLC1A5TAAR1KIF11ALPIPKM
SCHEMBL5324553 0.90 SLC1A5 (0.51) SLC1A5TAAR1KIF11ALPIPKM
SCHEMBL14381171 0.90 SLC1A5 (0.51) SLC1A5TAAR1KIF11ALPIPKM
SCHEMBL5323887 0.89 SLC1A5 (0.50) SLC1A5TAAR1KIF11NOS1GRIK1
SCHEMBL27255580 0.82 SLC1A5 (0.48) SLC1A5TAAR1KIF11NOS3NOS1
SCHEMBL43865 0.82 NOS3 (0.59) SLC1A5ALPIPKMPTGS1XIAP
SCHEMBL383453 0.82 NOS3 (0.59) SLC1A5ALPIPKMPTGS1XIAP
SCHEMBL29379111 0.82 NOS3 (0.59) SLC1A5ALPIPKMPTGS1XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024148312-A1 COMPOSITIONS, SYSTEMS, AND METHODS FOR AMINO ACID SYNTHESIS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-07-11 WO claimed
WO-2024148312-A1 COMPOSITIONS, SYSTEMS, AND METHODS FOR AMINO ACID SYNTHESIS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-07-11 WO disclosed
CN-113692401-A Process for producing aromatic amino acid derivative 中外制药株式会社 2021-11-23 CN disclosed
WO-2020189540-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE 中外製薬株式会社 2020-09-24 WO disclosed
US-20070258899-A1 Diagnostic and therapeutic agents KARYON-CTT LTD (FI) 2007-11-08 US disclosed
WO-2007113385-A1 DIAGNOSTIC AND THERAPEUTIC AGENTS KARYON-CTT LTD (FI) 2007-10-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070258899-A1 Diagnostic and therapeutic agents YBX1, MLX, TPX2 SLC1A5 3692/4885TAAR1 4667/4885KIF11 1678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.